Proud Moment for India as SS Innovations Rings the Nasdaq Bell, Celebrating a Global Milestone for ‘Made in India’ Surgical Robotics
In a moment of immense pride for the nation, SS Innovations International Inc., the pioneering Indian medical technology company behind the SSI Mantra Surgical Robotic System, rang the opening bell at Nasdaq MarketSite in New York City, marking a historic milestone for Indian innovation on the global stage. The company’s shares are now officially trading under the ticker symbol ‘SSII’.
The ceremony was led by Dr. Sudhir Srivastava, Founder, Chairman, and CEO of SS Innovations International, joined by members of the leadership team, board of directors, and special guests. The event stands as a reflection of India’s growing leadership in advanced medical robotics and its emergence as a hub for cutting-edge healthcare technology.
Founded with a mission to make advanced robotic surgery both accessible and affordable, SS Innovations has made remarkable progress with its clinically validated and patented SSI Mantra Surgical Robotic System. The technology is now installed in 80 hospitals across 75 locations in India and has expanded globally to Nepal, Ecuador, Guatemala, the Philippines, Indonesia, Sri Lanka, Colombia, and Ukraine.
With over 4,000 successful robotic surgeries performed across 100 different procedures, SSI Mantra is empowering hospitals and surgeons with precision, safety, and affordability—a rare combination in the world of robotic surgery. As the company prepares for expansion into Europe and the United States, SS Innovations continues to place India firmly at the center of a new era in medical robotics and healthcare innovation.
Reflecting on this milestone, Dr. Sudhir Srivastava shared, “Today’s bell-ringing ceremony marks a proud moment for all of us at SS Innovations International, commemorating our successful uplisting to Nasdaq in April 2025. This milestone reflects the relentless dedication of our team in developing the SSI Mantra—an advanced, cost-effective, and world-class surgical robotic system designed and built in India.
We are celebrating the completion of over 4,000 robotic procedures across more than 100 types of surgeries, with zero complications, injuries, or mortalities—a true testament to the system’s safety and precision. The SSI Mantra is gaining strong traction among surgeons not just across India but in several other countries, and we are now actively working toward expansion into the European Union and the United States. Our mission remains clear: to make cutting-edge robotic surgery accessible and affordable for patients worldwide, with India leading that transformation.”
For the year ending December 31, 2024, SS Innovations International reported a revenue of $20.6 million, marking a 3.5x increase from $5.9 million in 2023. The company’s gross margin also rose sharply—from 12.3% in 2023 to 40.9% in 2024—demonstrating strong operational performance and growing investor confidence.
The Nasdaq bell ringing by SS Innovations International is more than just a corporate milestone—it is a symbol of India’s rise as a global force in healthcare technology. It celebrates the spirit of innovation, the power of indigenous engineering, and the belief that technology born in India can touch lives around the world.
From concept to creation, SSI Mantra stands as a proud embodiment of the idea of ‘Made in India, for the World’—a revolution that is redefining access to robotic surgery and reshaping the future of global healthcare.
